Published in Mult Scler on October 15, 2008
Familial neuromyelitis optica. Neurology (2010) 1.14
New insights into neuromyelitis optica. J Clin Neurol (2011) 1.09
Epidemiology of neuromyelitis optica in Latin America. Mult Scler J Exp Transl Clin (2017) 0.75
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet (1989) 2.94
Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain (2001) 2.34
Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology (2008) 2.27
CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2006) 2.19
[The neuropathy epidemic in Cuba: eight years of investigation and follow-up]. Rev Neurol (2005) 2.06
P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology (2002) 2.05
[Immunological disorders in epileptic patients are associated to the epileptogenic focus localization]. Rev Neurol (2004) 2.01
SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome. Neurology (2007) 2.00
Analysis of relapses in anti-NMDAR encephalitis. Neurology (2011) 1.98
Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol (2001) 1.90
Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology (2003) 1.79
[Prions and blood donation]. Med Clin (Barc) (2001) 1.72
GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology (2011) 1.71
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70
Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology (1990) 1.67
Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. Eur J Neurol (2012) 1.62
Neuromodulation of the posterolateral hypothalamus for the treatment of chronic refractory cluster headache: Experience in five patients with a modified anatomical target. Cephalalgia (2011) 1.47
The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology (2010) 1.44
[Limb shaking and loss of consciousness: a carotid-basilar artery syndrome]. Neurologia (1995) 1.44
[Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy]. Nefrologia (2011) 1.38
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. Tissue Antigens (1999) 1.35
Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology (2000) 1.28
Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang (1995) 1.26
Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes. J Neuroimmunol (2005) 1.24
The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun (2010) 1.22
Immunohistochemical analysis of lymphoid and macrophage cell subsets and their immunologic activation markers in temporal arteritis. Influence of corticosteroid treatment. Arthritis Rheum (1989) 1.21
Protein kinase Cgamma autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer. J Neurol Neurosurg Psychiatry (2006) 1.18
Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke (1995) 1.17
Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology (Oxford) (2003) 1.11
[Limbic encephalitis: a probably under-recognized syndrome]. Neurologia (2005) 1.10
[Actual status of multiple sclerosis in Cuba. National cooperative group for the clinical trial "Recombinant interferon alpha-2b in multiple sclerosis"]. Rev Neurol (2000) 1.07
Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion. Am J Hum Genet (1996) 1.06
Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia. Neurology (2007) 1.03
Value of Hu antibody determinations in the follow-up of paraneoplastic neurologic syndromes. Neurology (2004) 1.02
Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler (2007) 1.02
Collagen graft interposition in vesicovaginal fistula treatment. Urol Int (2009) 1.01
[Epidemic neuropathy: proposal and arguments to rename Strachan disease as Strachan and Madan disease]. Rev Neurol (1997) 1.00
Evidence for linkage between the loci coding for the binding protein for the fourth component of human complement (C4BP) and for the C3b/C4b receptor. Proc Natl Acad Sci U S A (1984) 0.99
Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol (2004) 0.96
CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol (2007) 0.95
Relapsing neuromyelitis optica: long term history and clinical predictors of death. J Neurol Neurosurg Psychiatry (2009) 0.95
Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler (2007) 0.95
Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult Scler (2008) 0.93
Corticosteroids, ibuprofen, and acetaminophen for IFNbeta-1a flu symptoms in MS: a randomized trial. Neurology (2004) 0.92
Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens. Leukemia (2007) 0.92
Cerebellar ataxia associated with neuroendocrine thymic carcinoma and GAD antibodies. J Neurol Neurosurg Psychiatry (2009) 0.92
Midbrain lesions and paroxysmal dysarthria in multiple sclerosis. Mult Scler (2008) 0.90
Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting. Rheumatology (Oxford) (2003) 0.90
Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology (1996) 0.90
ANKRD55 and DHCR7 are novel multiple sclerosis risk loci. Genes Immun (2011) 0.89
Paraneoplastic encephalomyelitis associated with pancreatic tumor and anti-GAD antibodies. Neurology (2006) 0.88
Correlation between residual beta-cell function and islet cell antibodies in newly diagnosed type I diabetes. Follow-up study. Diabetes (1989) 0.88
Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases. J Am Acad Dermatol (1988) 0.88
Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect? J Immunol (1995) 0.88
HLA class II genes in soybean epidemic asthma patients. Am J Respir Crit Care Med (1997) 0.86
Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen. Arthritis Rheum (1988) 0.86
MspI polymorphism of the human p53 gene. Nucleic Acids Res (1990) 0.85
Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler (2009) 0.85
High levels of p53 protein expression do not correlate with p53 mutations in hepatocellular carcinoma. J Viral Hepat (2004) 0.85
A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS. Mult Scler (2013) 0.85
Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy. Neurology (2000) 0.84
Replication of top markers of a genome-wide association study in multiple sclerosis in Spain. Genes Immun (2010) 0.84
Autoimmune enteropathy in an adult with autoimmune multisystemic involvement. Scand J Gastroenterol (2002) 0.84
Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells. Cytometry (1998) 0.84
Immunocytochemical evidence on the effects of glucocorticoids on type I collagen synthesis in human osteoblastic cells. Calcif Tissue Int (2003) 0.83
Early anticoagulation after large cerebral embolic infarction: a safety study. Neurology (1995) 0.83
Assessment of synthetic peptides for hepatitis A diagnosis using biosensor technology. J Immunol Methods (2000) 0.83
[Clinical spectrum associated with aquaporin-4 antibodies (NMO-IgG)]. Neurologia (2010) 0.83
Use of linear and multiple antigenic peptides in the immunodiagnosis of acute hepatitis A virus infection. J Immunol Methods (2000) 0.83
No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis. J Neurol (2001) 0.83
Upper-limb dystonia secondary to a midbrain hemorrhage. Mov Disord (1996) 0.82
Effect of glatiramer acetate (Copaxone) on the immunophenotypic and cytokine profile and BDNF production in multiple sclerosis: a longitudinal study. Neurosci Lett (2006) 0.82
Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids. Clin Rheumatol (2006) 0.82
Splenic artery aneurysm presenting with abdominal discomfort and weight loss. Acta Clin Belg (2014) 0.82
Analysis of antibodies to neuronal surface antigens in adult opsoclonus-myoclonus. J Neuroimmunol (2008) 0.82
[Mucopolysaccharidosis type I in the Cuban population]. Rev Neurol (2003) 0.81
T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity. Clin Exp Immunol (2002) 0.81
CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS. J Neurol (2004) 0.80
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis. Mult Scler (2011) 0.80
Hepatitis C virus-associated membranoproliferative glomerulonephritis in renal allografts. J Am Soc Nephrol (1996) 0.80
White matter abnormalities in primary Sjögren syndrome. QJM (2011) 0.80
14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis. Neurology (2001) 0.80
[Typical absence epilepsy in a patient with serious cranio-encephalic trauma]. Rev Neurol (2000) 0.79
Transplantation of kidneys from donors with hepatitis C antibody into recipients with pre-transplantation anti-HCV. Kidney Int (1995) 0.79
Serum neuron-specific enolase and S100 calcium binding protein B biomarker levels do not improve diagnosis of acute stroke. J R Coll Physicians Edinb (2012) 0.79
Familial IgA nephropathy: report of two cases and brief review of the literature. Arch Intern Med (1980) 0.79
Benign adenomyoepithelioma of the breast: imaging findings mimicking malignancy and histopathological features. Acta Radiol (2007) 0.79
Periventricular white matter lucencies in patients with lacunar stroke. A marker of too high or too low blood pressure? Arch Neurol (1997) 0.79
Value of NMO-IgG determination at the time of presentation as CIS. Neurology (2012) 0.79
Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice. J Immunol Methods (2011) 0.79
Hu-antibody-positive patients with or without cancer have similar clinical profiles. J Neurol Neurosurg Psychiatry (2006) 0.78
Contribution of arterial blood pressure to the clinical expression of lacunar infarction. Stroke (1996) 0.78
CT evaluation of gastric wall pathology. Br J Radiol (1999) 0.78
Isolated paraneoplastic optic neuropathy associated with small-cell lung cancer and anti-CV2 antibodies. J Neurol (2007) 0.78
Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trial. Diabet Med (1999) 0.78
Clinical characteristics, beta-cell function, HLA class II and mutations in MODY genes in non-paediatric subjects with Type 1 diabetes without pancreatic autoantibodies. Diabet Med (2005) 0.78